Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage

Li,Xiong; Wang,Rong; Wang,Xuejiang; Xue,Xiaowei; Ran,Duan; Wang,Shuo

doi:10.3892/mmr.2013.1332

Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage

Authors:
- Xiong Li
- Rong Wang
- Xuejiang Wang
- Xiaowei Xue
- Duan Ran
- Shuo Wang
View Affiliations

Affiliations: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Chongwen, Beijing 100050, P.R. China, Department of Pathophysiology, Capital Medical University, Beijing 100069, P.R. China
Published online on: February 20, 2013 https://doi.org/10.3892/mmr.2013.1332
Pages: 1261-1266

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the association of inflammatory cytokines and matrix metalloproteinase-9 (MMP-9) with cerebral arteriovenous malformation (AVM) and hemorrhage. A total of 31 AVM patients were divided into groups according to specimen sources; a ruptured group with 14 patients and an unruptured group with 17 patients. The control group comprised 30 epilepsy patients who underwent temporal lobectomy. Peripheral blood was obtained from the 30 control and all 31 AVM patients preoperatively. Tissue samples were removed from the AVM nidus during surgery or from the temporal lobes of patients undergoing surgical treatment for epilepsy. Enzyme‑linked immunosorbent assay (ELISA) was used to measure plasma interleukin (IL)-6 levels. Western blot analysis was used to measure the levels of MMP-9 and transcription factors NF-κB and IκBα in the tissues. Immunofluorescence was used to measure tissue MMP-9 expression in each group. Gelatin zymography revealed the expression of activated MMP-2 and MMP-9 in the tissues. All the specimens were analyzed by routine hematoxylin and eosin (H&E) staining. IL-6 levels in the blood of the ruptured group were significantly higher compared with those of the unruptured and control groups (33.25±4.77 vs. 23.79±1.20, P<0.05; and 33.25±4.77 vs. 15.56±0.97, P<0.0001, respectively). NF-κB expression in the AVM ruptured group was significantly higher compared with that of the control group (5.00±0.12 vs. 2.36±0.33, P<0.05), but not with the unruptured group (5.00±0.12 vs. 2.96±0.69, P >0.05). The expression levels of IκBα in the ruptured and unruptured groups were similar to each other, but significantly less than those in the control group (0.12±0.02 vs. 1.27±0.06, P<0.001; and 0.45±0.15 vs. 1.27±0.06, P<0.01, respectively). MMP-9 protein expression levels in the unruptured group were increased compared with those in the control and ruptured groups (1.21±0.34 vs. 0.35±0.06, P<0.05; and 1.21±0.34 vs. 0.32±0.08, P<0.05, respectively). Gelatin zymography showed that the activity of MMP-9 was significantly higher in the ruptured compared with the unruptured and control groups (0.97±0.08 vs. 0.40±0.09, P<0.01; and 0.97±0.08 vs. 0.30±0.07, P<0.01, respectively). In the ruptured group, active MMP-2 expression levels were significantly higher compared with those in the other two groups (1.36±0.17 vs. 0.55±0.12, P=0.019; 1.36±0.17 vs. 0.36±0.09, P=0.006). The levels of IL-6 in the blood correlated with the tissue levels of activated MMP-9 (r=0.1691, P=0.0240). In conclusion, IL-6 expression levels were increased in the plasma of patients with cerebral AVM and this correlated with the activated MMP-9 levels of AVM tissues. Thus, plasma IL-6 levels are a potential predictor of hemorrhage risk in AVM patients.

View Figures

View References

1	ApSimon HT, Reef H, Phadke RV and Popovic EA: A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke. 33:2794–2800. 2002. View Article : Google Scholar : PubMed/NCBI
2	Crawford PM, West CR, Chadwick DW and Shaw MD: Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry. 49:1–10. 1986. View Article : Google Scholar : PubMed/NCBI
3	Fults D and Kelly DL Jr: Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery. 15:658–662. 1984. View Article : Google Scholar : PubMed/NCBI
4	Martin NA and Vinters HV: Arteriovenous malformations. Neurovascular Surgery. Carter LP, Spetzler RF and Hamilton MG: McGraw-Hill; New York: pp. 875–903. 1994
5	Chen Y, Pawlikowska L, Yao JS, et al: Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol. 59:72–80. 2006. View Article : Google Scholar : PubMed/NCBI
6	Okazaki S, Furukado S, Abe Y, et al: Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients. Cerebrovasc Dis. 30:180–187. 2010. View Article : Google Scholar : PubMed/NCBI
7	Chen Y, Zhu W, Bollen AW, et al: Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery. 62:1340–1350. 2008. View Article : Google Scholar : PubMed/NCBI
8	Fishman D, Faulds G, Jeffery R, et al: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 102:1369–1376. 1998. View Article : Google Scholar : PubMed/NCBI
9	Feiler S, Plesnila N, Thal SC, et al: Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis. 32:289–295. 2011. View Article : Google Scholar
10	Loftus IM, Naylor AR, Goodall S, et al: Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke. 31:40–47. 2000. View Article : Google Scholar : PubMed/NCBI
11	Chyatte D and Lewis I: Gelatinase activity and the occurrence of cerebral aneurysms. Stroke. 28:799–804. 1997. View Article : Google Scholar : PubMed/NCBI
12	Sandalcioglu IE, Asgari S, Wende D, et al: Proliferation activity is significantly elevated in partially embolized cerebral arteriovenous malformations. Cerebrovasc Dis. 30:396–401. 2010. View Article : Google Scholar
13	Choi EJ, Walker EJ, Shen F, et al: Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis. 33:540–547. 2012. View Article : Google Scholar
14	Terry CF, Loukaci V and Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 275:18138–18144. 2000. View Article : Google Scholar : PubMed/NCBI
15	Rundek T, Elkind MS, Pittman J, et al: Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke. 33:1420–1423. 2002. View Article : Google Scholar
16	Jones KG, Brull DJ, Brown LC, et al: Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 103:2260–2265. 2001. View Article : Google Scholar : PubMed/NCBI
17	Brull DJ, Leeson CP, Montgomery HE, et al: The effect of the Interleukin-6-174G>C promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest. 32:153–157. 2002.
18	Acalovschi D, Wiest T, Hartmann M, et al: Multiple levels of regulation of the interleukin-6 system in stroke. Stroke. 34:1864–1869. 2003. View Article : Google Scholar : PubMed/NCBI
19	Hernández-Rodríguez J, Segarra M, Vilardell C, et al: Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation. 107:2428–2434. 2003.
20	Hashimoto T, Lawton MT, Wen G, et al: Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery. 54:410–425. 2004. View Article : Google Scholar : PubMed/NCBI
21	Aoki Y, Jaffe ES, Chang Y, et al: Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 93:4034–4043. 1999.PubMed/NCBI
22	Gaudino M, Andreotti F, Zamparelli R, et al: The-174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 108(Suppl 1): II195–II199. 2003. View Article : Google Scholar
23	Pola R, Flex A, Gaetani E, et al: Synergistic effect of -174G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke. 34:881–885. 2003. View Article : Google Scholar : PubMed/NCBI
24	Flex A, Gaetani E, Pola R, et al: The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 24:264–268. 2002. View Article : Google Scholar : PubMed/NCBI
25	Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
26	Brinckerhoff CE and Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 3:207–214. 2002. View Article : Google Scholar : PubMed/NCBI
27	Chen Y, Pawlikowska L, Yao JS, et al: Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol. 59:72–80. 2006. View Article : Google Scholar : PubMed/NCBI
28	Hashimoto T, Wu Y, Lawton MT, et al: Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery. 56:1058–1065. 2005.PubMed/NCBI
29	Achrol AS, Pawlikowska L, McCulloch CE, et al: Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke. 37:231–234. 2006.
30	Kim H, Hysi PG, Pawlikowska L, et al: Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis. 27:176–182. 2009. View Article : Google Scholar : PubMed/NCBI